This inventor holds 1 USPTO granted patent. Top assignee: Akebia Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hirotoshi Yagishita: Innovator in Pharmaceutical Chemistry
Introduction
Hirotoshi Yagishita is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medicinal use. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this specialized area.
Latest Patents
Hirotoshi Yagishita holds a patent for a "Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative." This invention provides a novel process for preparing the compound I, which includes the compounds vadadustat and roxadustat. These compounds are recognized for their potential medicinal applications. The process involves reacting specific compounds with carbon monoxide in the presence of a palladium catalyst, which can be conducted with or without a ligand and in the presence of a base and solvent.
Career Highlights
Yagishita is currently associated with Akebia Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective pharmaceutical solutions. His contributions have been instrumental in the progress of new therapeutic agents.
Collaborations
Hirotoshi Yagishita collaborates with notable colleagues, including Kazufumi Ootsuki and Muneki Kishida. These partnerships enhance the research environment and foster the exchange of ideas, leading to further advancements in their respective fields.
Conclusion
Hirotoshi Yagishita is a distinguished inventor whose work in pharmaceutical chemistry has led to significant innovations. His patent for a method of producing nitrogen-containing heteroarylcarboxamide acetic acid derivatives exemplifies his contributions to medicine. His ongoing efforts at Akebia Therapeutics, Inc. continue to shape the future of pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
